Aclarion, Inc. (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company, today announced the release of a new physician video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon at The London Clinic, one of the United Kingdom's leading private hospitals. The video, available here, highlights Sutcliffe's experience using Nociscan in his clinical practice.
With more than 30 years of experience, Sutcliffe serves as Lead Clinician at The London Spine Clinic and frequently handles complex spinal cases. In the video, he notes that Nociscan provides an additional layer of insight that complements traditional imaging. "Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain," Sutcliffe said.
To date, nearly 100 Nociscans have been conducted at The London Clinic, reflecting sustained physician engagement and growing integration into routine clinical practice. Nociscan is a non-invasive solution that uses MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain, helping physicians differentiate between painful and non-painful discs in the lumbar spine.
"Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain," said Brent Ness, Chief Executive Officer of Aclarion.
Chronic low back pain affects approximately 266 million people worldwide. According to Aclarion, when Nociscan is used alongside other diagnostic tools, clinical data has demonstrated up to a 97% surgical success rate when all Nociscan-positive discs are treated. More information about Nociscan can be found at www.aclarion.com, and a site map of Nociscan centers is available here.
